ACR Appropriateness Criteria® Hematospermia

Expert Panel on Urologic Imaging:

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Most men with hematospermia or hemospermia (HS) are young (<40 years of age), presenting with transient or episodic HS without other signs or symptoms of disease. The condition is self-limiting in most cases and idiopathic in nature. When a cause can be identified, infections of the urogenital tract are the most common. Imaging does not play a role in this patient population. In older men (>40 years of age), clinical screening for prostate cancer is advised. Furthermore, when HS is persistent or has symptoms, causes include obstruction or stricture at the level of the verumontanum, calcifications or calculi in the prostate, ejaculatory ducts or seminal vesicles, and cysts arising within these structures. Noninvasive imaging, predominantly transrectal ultrasound (TRUS) and MRI, can be used in men of any age with persistent or refractory HS, or other associated symptoms or signs. TRUS is considered as the first-line imaging with MRI used when TRUS is inconclusive or negative. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

Original languageEnglish (US)
Pages (from-to)S154-S159
JournalJournal of the American College of Radiology
Volume14
Issue number5
DOIs
StatePublished - May 1 2017

Fingerprint

Hemospermia
Ejaculatory Ducts
Guidelines
Seminal Vesicles
Calculi
Expert Testimony
Radiology
Signs and Symptoms
Cysts
Prostate
Prostatic Neoplasms
Pathologic Constriction
Therapeutics

Keywords

  • Appropriate Use Criteria
  • Appropriateness Criteria
  • AUC
  • hematospermia
  • hemospermia
  • MRI
  • TRUS
  • ultrasound

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

ACR Appropriateness Criteria® Hematospermia. / Expert Panel on Urologic Imaging:.

In: Journal of the American College of Radiology, Vol. 14, No. 5, 01.05.2017, p. S154-S159.

Research output: Contribution to journalArticle

Expert Panel on Urologic Imaging:. / ACR Appropriateness Criteria® Hematospermia. In: Journal of the American College of Radiology. 2017 ; Vol. 14, No. 5. pp. S154-S159.
@article{efef0f15a7b64298a3de15d74831fc60,
title = "ACR Appropriateness Criteria{\circledR} Hematospermia",
abstract = "Most men with hematospermia or hemospermia (HS) are young (<40 years of age), presenting with transient or episodic HS without other signs or symptoms of disease. The condition is self-limiting in most cases and idiopathic in nature. When a cause can be identified, infections of the urogenital tract are the most common. Imaging does not play a role in this patient population. In older men (>40 years of age), clinical screening for prostate cancer is advised. Furthermore, when HS is persistent or has symptoms, causes include obstruction or stricture at the level of the verumontanum, calcifications or calculi in the prostate, ejaculatory ducts or seminal vesicles, and cysts arising within these structures. Noninvasive imaging, predominantly transrectal ultrasound (TRUS) and MRI, can be used in men of any age with persistent or refractory HS, or other associated symptoms or signs. TRUS is considered as the first-line imaging with MRI used when TRUS is inconclusive or negative. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.",
keywords = "Appropriate Use Criteria, Appropriateness Criteria, AUC, hematospermia, hemospermia, MRI, TRUS, ultrasound",
author = "{Expert Panel on Urologic Imaging:} and Keyanoosh Hosseinzadeh and Aytekin Oto and Allen, {Brian C.} and Fergus Coakley and Barak Friedman and Fulgham, {Pat F.} and Hartman, {Matthew S.} and Heller, {Matthew T.} and Christopher Porter and Sahni, {V. Anik} and Sudakoff, {Gary S.} and Sadhna Verma and Wang, {Carolyn L.} and Yoo, {Don C.} and Remer, {Erick M.} and Eberhardt, {Steven C.}",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.jacr.2017.02.023",
language = "English (US)",
volume = "14",
pages = "S154--S159",
journal = "Journal of the American College of Radiology",
issn = "1558-349X",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - ACR Appropriateness Criteria® Hematospermia

AU - Expert Panel on Urologic Imaging:

AU - Hosseinzadeh, Keyanoosh

AU - Oto, Aytekin

AU - Allen, Brian C.

AU - Coakley, Fergus

AU - Friedman, Barak

AU - Fulgham, Pat F.

AU - Hartman, Matthew S.

AU - Heller, Matthew T.

AU - Porter, Christopher

AU - Sahni, V. Anik

AU - Sudakoff, Gary S.

AU - Verma, Sadhna

AU - Wang, Carolyn L.

AU - Yoo, Don C.

AU - Remer, Erick M.

AU - Eberhardt, Steven C.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Most men with hematospermia or hemospermia (HS) are young (<40 years of age), presenting with transient or episodic HS without other signs or symptoms of disease. The condition is self-limiting in most cases and idiopathic in nature. When a cause can be identified, infections of the urogenital tract are the most common. Imaging does not play a role in this patient population. In older men (>40 years of age), clinical screening for prostate cancer is advised. Furthermore, when HS is persistent or has symptoms, causes include obstruction or stricture at the level of the verumontanum, calcifications or calculi in the prostate, ejaculatory ducts or seminal vesicles, and cysts arising within these structures. Noninvasive imaging, predominantly transrectal ultrasound (TRUS) and MRI, can be used in men of any age with persistent or refractory HS, or other associated symptoms or signs. TRUS is considered as the first-line imaging with MRI used when TRUS is inconclusive or negative. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

AB - Most men with hematospermia or hemospermia (HS) are young (<40 years of age), presenting with transient or episodic HS without other signs or symptoms of disease. The condition is self-limiting in most cases and idiopathic in nature. When a cause can be identified, infections of the urogenital tract are the most common. Imaging does not play a role in this patient population. In older men (>40 years of age), clinical screening for prostate cancer is advised. Furthermore, when HS is persistent or has symptoms, causes include obstruction or stricture at the level of the verumontanum, calcifications or calculi in the prostate, ejaculatory ducts or seminal vesicles, and cysts arising within these structures. Noninvasive imaging, predominantly transrectal ultrasound (TRUS) and MRI, can be used in men of any age with persistent or refractory HS, or other associated symptoms or signs. TRUS is considered as the first-line imaging with MRI used when TRUS is inconclusive or negative. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

KW - Appropriate Use Criteria

KW - Appropriateness Criteria

KW - AUC

KW - hematospermia

KW - hemospermia

KW - MRI

KW - TRUS

KW - ultrasound

UR - http://www.scopus.com/inward/record.url?scp=85018409957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018409957&partnerID=8YFLogxK

U2 - 10.1016/j.jacr.2017.02.023

DO - 10.1016/j.jacr.2017.02.023

M3 - Article

VL - 14

SP - S154-S159

JO - Journal of the American College of Radiology

JF - Journal of the American College of Radiology

SN - 1558-349X

IS - 5

ER -